Thioridazine

Thioridazine 10-[2-(1-methyl-2-piperidyl)etilo]-2-methylsulfanyl- phenothiazine CAS number ? ATC code N05AC02 Chemical formula C21H26N2S2 Molecular weight 370.577 g/mol Bioavailability incomplete Metabolism hepatic Elimination half-life 7-13hours (up to 20hours) Excretion feces Pregnancy category Only if clearly needed Legal status RX-only-medication, non-narcotic Routes of administration oral (tabletts, concentration, sometimes syrup) Thioridazine is a piperidine phenothiazine antipsychotic drug and is used in the treatment of schizophrenia and psychosis. Thioridazine is a typical low-potency neuroleptic that is slighly less potent than chlorpromazine. It has a halflife of 7 Para 13 horas. (Other sources have 16 Para 24 horas.) It has the advantage of a low incidence of early and late extrapyramidal side-effects (tardive dyskinesia). In this regard it is very similar to the atypical neuroleptic clozapine (Clozaril®). Thioridazine has also intrinsic mild to moderate antidepressive properties. It has antiemetic properties. Sedation is said to be less pronounced compared with chlorpromazine. Contenido 1 Indicaciones 2 Metabolismo 3 Efectos secundarios 4 Discontinuation 5 Historia 6 References and End Notes 7 External links Indications Previous additional indications were agitated depression, tension and anxiety linked to alcohol withdrawal and dysphoria of epileptic patients. It had even (Melleretten® in Europe) an indication for the treatment of psychosis in children and adolescents (10mg to 60mg daily). It was also given off-label for the treatment of insomnia and for alleviation of opiate withdrawal. Thioridazine is known to kill multidrug-resistant mycobacterium tuberculosis and MRSA at clinical concentrations..[1] Metabolism Thioridazine is a racemic compound with two enantiomers, both of which are metabolized, according to Eap et al, by CYP2D6 into (S)- y (R)-thioridazine 2-sulfoxide, better known as mesoridazine,[2] and into (S)- y (R)-thioridazine-5-sulfoxide.[3] Mesoridazine is in turn metabolized into sulforidazine.[4] Thioridazine is an inhibitor of CYP1A2 and CYP3A2[5] Side Effects Central nervous system side-effects occur. These are mainly drowsiness, mareo, fatiga, and vertigo. Early and late extrapyramidal side-effects are seen only infrequently (menos que 1% altogether). There is no clear dose-effect relationship, as with higher doses anticholinergic effects of thioridazine become more prominent. Thioridazine causes also an unusual high incidence of impotence and anorgasmia due to a strong alpha-blocking activity. Painful ejaculation or no ejaculation at all is also sometimes seen. Autonomous side-effects (boca seca, urination-difficulties, obstipation, induction of glaucoma, postural hypotension, and sinus tachycardia) occur obviously less often than with most other mildly potent antisychotics. Thioridazine is no longer recommended as first-line treatment due its side-effect of prolonging the QT interval on the EKG. Thioridazine-5-sulfoxide is responsible for the (ventricular tachycardia, torsades de pointes) according to Heath, Svensson and Martensson.[6] Además, the serious and sometimes fatal blood damage agranulocytosis is seen more frequently (aproximadamente 1/500 Para 1/1,000 pacientes) with thioridazine than with other typical phenothiazines (1/2,000 Para 1/10,000 pacientes). Thioridazine if given over a prolonged time and in high doses can be stored in the ocula and the retina of the eyes and in the heart muscle. Clinical consequences (disturbed or blurred vision) are rare. Discontinuation It is advisable to withdraw thioridazine gradually and not abruptly to avoid unpleasant withdrawal symptoms (agitación, insomnio, ansiedad). Another neuroleptic may be introduced to the theraputic regime step by step (overlapping), if needed. If sudden withdrawal of thioridazine is necessary, withdrawal symptoms can also be alleviated with the benzodiazepines lorazepam (Ativan®) 1mg-2mg, alprazolam (Xanax®) 0,5mg prn or clonazepam (Klonopin®) 0,5mg to 2mg prn (según sea necesario) for up to 2 semanas (not longer to avoid addiction). History The manufacturer Novartis/Sandoz/Wander of the brands of thioridazine, Mellaril® in the USA and Canada and Melleril® in Europe, discontinued the drug worldwide in June 2005. The usual dosage was 50mg per day for mild cases to 600-800 mg per day for severely disturbed patients. Thioridazine may still be available from other manufacturers as a generic drug with the precaution that it is used only in psychotic patients refractory to other forms of drug treatment. EKG-monitoring and frequent white blood cell counts are required before initiating therapy and in close intervalls afterwards. This section is a stub. You can help by adding to it. References and End Notes ^ Amaral L, Viveiros M, Molnar J. "Antimicrobial activity of phenothiazines." In Vivo. 2004 Nov-Dic;18(6):725-31. PMID 15646813 ^ PubChem Substance Summary: Mesoridazine National Center for Biotechnology Information. ^ Eap CB, Guentert TW, Schaublin-Loidl M, Stabl M, Koeb L, Powell K, Baumann P. "Plasma levels of the enantiomers of thioridazine, thioridazine 2-sulfoxide, thioridazine 2-sulfone, and thioridazine 5-sulfoxide in poor and extensive metabolizers of dextromethorphan and mephenytoin." Clinical Pharmacology & Therapy. 1996 Estropear;59(3):322-31. PMID 8653995 ^ PubChem Substance Summary: Sulforidazine National Center for Biotechnology Information. ^ Daniel WA, Syrek M, Rylko Z, Kot M. "Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver." Polish Journal of Pharmacology. 2001 Nov-Dic;53(6):615-21. PMID 11985335 Fulltext (PDF) ^ Heath A, Svensson C, Martensson E. "Thioridazine toxicity--an experimental cardiovascular study of thioridazine and its major metabolites in overdose." Veterinay and Human Toxicology. 1985 Apr;27(2):100-5. PMID 3992882 Ahlenius, S., Heimann, M., & Larsson, K. (1979). Prolongation of the ejaculation latency in the male rat by thioridazine and chlorimipramine: Psicofarmacología Vol. 65(2) Oct 1979, 137-140. Aizenburg, D., Shiloh, R., Zemishlany, Z., & Weizman, Un. (1996). Low-dose imipramine for thioridazine-induced male orgasmic disorder: Journal of Sex & Marital Therapy Vol 22(3) Fal 1996, 225-229. Akpinar, S., Itil, T., Marasa, J., & Keskiner, Un. (1972). Clinical investigations and computer analysis of EEG effects of thioridazine hydrochloride on chronic schizophrenics: Psychiatria Clinica Vol 5(5) 1972, 289-299. Aman, M. G., Marcas, R. E., Turbott, S. H., Wilsher, C. PAGS., & et al. (1991). Clinical effects of methylphenidate and thioridazine in intellectually subaverage children: Journal of the American Academy of Child & Adolescent Psychiatry Vol 30(2) Estropear 1991, 246-256. Aman, M. G., Marcas, R. E., Turbott, S. H., Wilsher, C. PAGS., & et al. (1991). Methylphenidate and thioridazine in the treatment of intellectually subaverage children: Effects on cognitive-motor performance: Journal of the American Academy of Child & Adolescent Psychiatry Vol 30(5) Sep 1991, 816-824. Aman, M. G., & Singh, N. N. (1980). The usefulness of thioridazine for treating childhood disorders: Fact or folklore? : Revista estadounidense de deficiencia mental vol. 84(4) Ene 1980, 331-338. Aman, M. G., & White, Un. J. (1988). Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents: Revista de autismo y trastornos del desarrollo vol. 18(3) Sep 1988, 355-366. Ananth, J., & Lin, K.-m. (1986). SIADH: A serious side effect of psychotropic drugs: Revista Internacional de Psiquiatría en Medicina Vol 16(4) 1986-1987, 401-407. Anderton, L., & Bishop, P. (2001). Acute visual loss after thioridazine overdose: Revista Americana de Psiquiatría Vol 158(5) Mayo 2001, 818. Appelberg, B., Rimon, R., Nikkila, H., & Ahlroth, J. (1989). Neuroleptic-induced somnambulism as a cause of nocturnal confusion in a psychotic patient: A case description: Nordisk Psykiatrisk Tidsskrift Vol 43(5) 1989, 473-474. Arshad, PAGS., Morcos, M., & Sridharan, B. (2002). What happened to thioridazine?: Comentario: BMJ: British Medical Journal Vol 325(7370) Oct 2002, 968. Ather, S. Un., Shaw, S. H., & Stoker, M. J. (1986). A comparison of chlormethiazole and thioridazine in agitated confusional states of the elderly: Acta psiquiátrica Scandinavica vol. 73(329, Suppl) 1986, 81-91. axelsson, R. (1977). On the serum concentrations and antipsychotic effects of thioridazine, thioridazine side-chain sulfoxide and thioridazine side-chain sulfone, in chronic psychotic patients: Investigación terapéutica actual vol. 21(4) Apr 1977, 587-605. axelsson, R., & Martensson, E. (1976). Serum concentration and elimination from serum of thioridazine in psychiatric patients: Investigación terapéutica actual vol. 19(2) Feb 1976, 242-265. axelsson, R., & Martensson, E. (1978). Relationship between serum concentrations of thioridazine and its main nonconjugated metabolites and the clinical response in thioridazine-treated patients: Investigación terapéutica actual vol. 24(2) Jul 1978, 232-242. axelsson, R., & Ohman, R. (1987). Patterns of response to neuroleptic treatment: Factors influencing the amelioration of individual symptoms in psychotic patients: Acta psiquiátrica Scandinavica vol. 76(6) Dic 1987, 707-714. Ball, W. Un., & Caroff, S. N. (1986). Retinopathy, tardive dyskinesia, and low-dose thioridazine: Revista Americana de Psiquiatría Vol 143(2) Feb 1986, 256-257. Barnes, R., & et al. (1982). Efficacy of antipsychotic medications in behaviorally disturbed dementia patients: Revista Americana de Psiquiatría Vol 139(9) Sep 1982, 1170-1174. Bastecky, J., Kvasnicka, J., Vortel, J., Zapletalek, M., & et al. (1990). Suicidal ingestion of thioridazine as the cause of severe impairment of the cardiac rhythm: Polymorphous ventricular tachycardia: Ceska a Slovenska Psychiatrie Vol 86(4) Ago 1990, 264-268. Baxley, G. B. (1974). Effects of psychotropic drugs on the short-term memory of retarded children: Resúmenes de disertación internacional. Beale, Yo. L., Herrero, O. Un., & Webster, D. M. (1993). Effects of chlorpromazine and thioridazine on discrimination learning in children with mental retardation: Journal of Developmental and Physical Disabilities Vol 5(1) Estropear 1993, 43-54. Bennett, J. Un., & et al. (1984). Combined thioridazine and desipramine: Early antidepressant response: Psicofarmacología Vol. 82(3) 1984, 263-265. Bergling, R., & et al. (1975). Plasma levels and clinical effects of thioridazine and thiothixene: Journal of Clinical Pharmacology Vol 15(2-3) febrero-marzo 1975, 178-186. Bisset, Un. F. (2002). Risks must be balanced: Comentario: BMJ: British Medical Journal Vol 325(7370) Oct 2002, 967-968. Blackburn, J. R. (1990). The role of dopamine in preparatory and consummatory defensive behaviours: Resúmenes de disertación internacional. Blackburn, J. R., & Phillips, Un. G. (1989). Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: Implications for screening new antipsychotic drugs: Psicofarmacología Vol. 98(4) Ago 1989, 453-459. Blackburn, J. R., Phillips, Un. G., & Fibiger, H. C. (1989). Dopamine and preparatory behavior: III. Effects of metoclopramide and thioridazine: Neurociencia conductual vol. 103(4) Ago 1989, 903-906. Bowers, M. B., & Rozitis, Un. (1976). Brain homovanillic acid: Regional changes over time with antipsychotic drugs: European Journal of Pharmacology Vol 39(1) Sep 1976, 109-115. Brahm, N. C., Buswell, Un., Christensen, D., & Brown, R. D. (2003). Para. 23(3) Jun 2003, 314-315. Breuning, S. E., Davis, V. J., Matson, J. L., & Ferguson, D. G. (1982). Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults: Revista Americana de Psiquiatría Vol 139(11) Nov 1982, 1447-1454. Breuning, S. E., Davis, V. J., Matson, J. L., & Ferguson, D. G. (1989). "Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults": Retraction: Revista Americana de Psiquiatría Vol 146(5) Mayo 1989, 634. Marrón, W. Un., Laughren, T. PAGS., & Williams, B. (1981). Differential effects of neuroleptic agents on the pituitary-gonadal axis in men: Archivos de Psiquiatría General Vol. 38(11) Nov 1981, 1270-1272. Burgio, L. D., Página, T. J., & Capriotti, R. M. (1985). Clinical behavioral pharmacology: Methods for evaluating medications and contingency management: Journal of Applied Behavior Analysis Vol 18(1) Spr 1985, 45-59. Buyze, G., Egberts, P. F., Muusze, R. G., & Poslavsky, Un. (1973). Blood levels of thioridazine and some of its metabolites in psychiatric patients: A preliminary report: Psychiatria, Neurologia, Neurochirurgia Vol 76(3) Mayo 1973, 229-239. Canon, J. G. (1979). A comparison of clozapine, chlorpromazine, and thioridazine upon DRL performance in the squirrel monkey: Psicofarmacología Vol. 64(1) 1979, 55-60. Carpintero, M. S. (1988). Effects of antipsychotic medication on discrimination learning in institutional mentally retarded adults: Resúmenes de disertación internacional. Carrillo, J. Un., ramos, S. Yo., Herriaz, Un. G., Llerena, Un., Agundez, J. Un. G., Berecz, R., et al. (1999). Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients: Revista de Psicofarmacología Clínica Vol. 19(6) Dic 1999, 494-499. Casat, C. D., & Wilson, D. C. (1986). Tics with combined thioridazine-methylphenidate therapy: Caso clínico: Revista de Psiquiatría Clínica Vol 47(1) Ene 1986, 44-45. Charalampous, K. D., Johnson, P. C., & Estevez, V. (1974). Absorption and excretion of thioridazine and mesoridazine in man: Diseases of the Nervous System Vol 35(11) Nov 1974, 494-496. Claghorn, J. L. (1972). A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children: Investigación terapéutica actual vol. 14(12) Dic 1972, 785-789. Clark, M. L., & et al. (1975). Pimozide in chronic schizophrenic outpatients: Diseases of the Nervous System Vol 36(3) Estropear 1975, 137-141. Cohen, B. M., & et al. (1980). Neuroleptic blood levels and therapeutic effect: Psicofarmacología Vol. 70(2) Oct 1980, 191-193. Cohen, B. M., & Lipinski, J. F. (1986). In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: Implications for drug mechanisms of action: Ciencias de la Vida Vol 39(26) Dic 1986, 2571-2580. Cohen, B. M., Lipinski, J. F., & Waternaux, C. (1989). A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites: Psicofarmacología Vol. 97(4) Apr 1989, 481-488. Cohen, B. M., & Sommer, B. R. (1988). Metabolism of thioridazine in the elderly: Revista de Psicofarmacología Clínica Vol. 8(5) Oct 1988, 336-339. Cohen, B. M., Wan, W., Froimowitz, M. PAGS., Ennulat, D. J., Cherkerzian, S., & Konieczna, H. (1998). Activation of midline thalamic nuclei by antipsychotic drugs: Psicofarmacología Vol. 135(1) Ene 1998, 37-43. Cohen, S. (1966). Thioridazine (Mellaril): Recent developments: Journal of Psychopharmacology 1(1) 1966, 1-15. Cohn, J. B., Brust, J., DiSerio, F., & Singer, J. (1985). Effect of bromocriptine mesylate on induced hyperprolactinemia in stabilized psychiatric outpatients undergoing neuroleptic treatment: Neuropsicobiología Vol 13(4) Sep 1985, 173-179. Costall, B., & Naylor, R. J. (1975). Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine: Psychopharmacologia Vol 43(1) 1975, 69-74. Cowen, T. D., & Meythaler, J. M. (1994). Hypotensive effects of thioridazine in an elderly patient with traumatic brain injury: Brain Injury Vol 8(8) Nov-Dic 1994, 735-737. Cowley, L. M., & Glen, R. S. (1979). Double-blind study of thioridazine and haloperidol in geriatric patients with a psychosis associated with organic brain syndrome: Revista de Psiquiatría Clínica Vol 40(10) Oct 1979, 411-419. Cozzo, G. (1964). Thioridazine in schizophrenia: L'Encephale 53(1) 1964, 281-284. Cuervo, T. J., Deakin, J. F., & Longden, Un. (1977). The nucleus accumbens: Possible site of antipsychotic action of neuroleptic drugs? : Medicina Psicológica Vol. 7(2) Mayo 1977, 213-221. Cuervo, T. J., & Gillbe, C. (1973). Dopamine antagonism and antischizophrenic potency of neuroleptic drugs: Nature-New Biology Vol 245(140) Sep 1973, 27-28. Crowley, T. J., & Hydinger-Macdonald, M. (1981). Motility, parkinsonism, and prolactin with thiothixene and thioridazine: Archivos de Psiquiatría General Vol. 38(6) Jun 1981, 668-675. Curtis, J. L. (1978). In vivo conversion of mesoridazine to thioridazine: Research Communications in Psychology, Psychiatry & Behavior Vol 3(3) 1978, 285-286. Daradkeh, T. K., & Ajlouni, K. M. (1988). The effect of neuroleptics on prolactinoma growth in a Jordanian schizophrenic girl: Acta psiquiátrica Scandinavica vol. 77(2) Feb 1988, 228-229. davies, S. J. C., Cooke, L. B., Moore, Un. G., & Potokar, J. (2002). Discontinuation of thioridazine in patients with learning disabilities: Balancing cardiovascular toxicity with adverse consequences of changing drugs: BMJ: British Medical Journal Vol 324(7352) Jun 2002, 1519-1521. Davis, J. M. (1973). Clinical pearls: Overdose of psychotropic drugs: Anales psiquiátricos vol. 3(6) Jun 1973, 6-11. de Jonghe, F. E., Schalken, H. F., & Van der Helm, H. J. (1976). Thioridazine in the treatment of depressive patients: Acta psiquiátrica Scandinavica vol. 53(4) Apr 1976, 271-276. De Jonghe, F. E., Van der Helm, H. J., Schalken, H. F., & Thiel, J. H. (1973). Therapeutic effect and plasma level of thioridazine: Acta psiquiátrica Scandinavica vol. 49(5) 1973, 535-545. Delay, J., Pichot, PAGS., Lemperiere, T., & Bailly, R. (1964). The use of thioridazine in psychiatry. Problems of dosage and secondary effects: L'Encephale 53(1) 1964, 192-195. Delay, J., Pichot, PAGS., Lemperiere, T., & Bailly, R. (1966). Psychopharmacological study of thioridazine at high doses: L'Encephale 55(2) 1966, 117-136. Dencker, S. J., & Fasth, B. G. (1986). Combination of psychotherapy and drugs in the treatment of neurosis: A controlled comparison of bromazepam and thioridazine: Acta psiquiátrica Scandinavica vol. 74(6) Dic 1986, 569-575. Diebold, K. (1971). Polythymolepsy (combined use of thymoleptics) in cases of endogenous depression: International Pharmacopsychiatry Vol 6(1) 1971, 45-51. Dolman, J., & Baker, R. (2002). "Grand rounds: Catatonia": Comentario: Boletín Psiquiátrico Vol. 26(10) Oct 2002, 393-394. Dubin, W. R., & et al. (1985). Rapid tranquilization: The efficacy of oral concentrate: Revista de Psiquiatría Clínica Vol 46(11) Nov 1985, 475-478. Dubuc, Yo., Protais, PAGS., Colboc, O., & Costentin, J. (1982). Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics: Neuropharmacology Vol 21(11) Nov 1982, 1203-1206. Dufresne, R. L., Valentino, D. Un., & Kass, D. J. (1993). Thioridazine improves affective symptoms in schizophrenic patients: Psychopharmacology Bulletin Vol 29(2) 1993, 249-255. Eccleston, D., & et al. (1985). The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia: Revista Británica de Psiquiatría Vol 147 Dic 1985, 623-630. Eccleston, D., & Hassanyeh, F. (1986). "Criteria for measuring change: Statistical significance vs clinical significance": Professor Eccleston and Dr. Hassanyeh reply: Revista Británica de Psiquiatría Vol 148 Jun 1986, 745. Elie, R., & et al. (1980). Comparison of SCH-12679 and thioridazine in aggressive mental retardates: El Diario Canadiense de Psiquiatría / La Revue canadienne de psychiatrie Vol 25(6) Oct 1980, 484-491. Engstrom, G., & Long, R. F. (1965). Relative effectiveness of Taractan on a chronic psychiatric female population in comparison with Mellaril and Thorazine: Current Conclusions No 3 1965, 26-27. Eryshev, O. F. (1986). Pharmacological correction of manifestations of the schizophrenic defect: Trudy Leningradskogo Nauchno-Issledovatel'skogo Psikhonevrologicheskogo Instituta im V M Bekhtereva Vol 113 1986, 62-69. Fann, W. E., Lago, C. R., & Majors, L. F. (1974). Thioridazine in neurotic, anxious, and depressed patients: Psicosomática: Revista de Consulta Liaison Psychiatry Vol 15(3) 1974, 117-121. Filip, V., & Balik, J. (1978). Possible indication of dopaminergic blockade in man by electroretinography: International Pharmacopsychiatry Vol 13(3) 1978, 151-156. Findlay, D. J., Sharma, J., McEwen, J., Ballinger, B. R., & et al. (1989). Double-blind controlled withdrawal of thioridazine treatment in elderly female inpatients with senile dementia: Revista internacional de psiquiatría geriátrica vol. 4(2) Mar-Abr 1989, 115-120. Fletcher, C. N. (1979). The effects of thioridazine withdrawal on the physical, social, cognitive and self care functioning of severely and profoundly retarded children: Resúmenes de disertación internacional. Foxworth, Un. M. (1972). The effect of thioridazine and dextroamphetamine on the behavior and cognition of elementary school children with behavior disorders: Dissertation Abstracts International Vol. Freixa i Baque, E., & Boyer, P. (1986). Spontaneous skin potential responses in depressed patients receiving an antidepressant and neuroleptic sequential treatment: Psychiatrie & Psychobiologie Vol 1(1) Apr 1986, 91-94. Frenchman, Yo. B., & Prince, T. (1997). Clinical experience with risperidone, haloperidol and thioridazine for dementia-associated behavioral disturbances: International Psychogeriatrics Vol 9(4) Dic 1997, 431-435. Gallucci, G., Buccino, D. L., & Cournoyer, M. (2003). Challenges related to thioridazine use in patients with mental retardation and developmental disabilities: Aspectos de salud mental de las discapacidades del desarrollo vol. 6(1) Enero-Mar 2003, 21-25. Gardos, G. (1981). Dystonic reaction during maintenance antipsychotic therapy: Revista Americana de Psiquiatría Vol 138(1) Ene 1981, 114-115. Georgotas, Un., & et al. (1981). A double-blind comparison of trebenzomine and thioridazine in the treatment of schizophrenia: Psicofarmacología Vol. 73(3) Mayo 1981, 292-294. Ghaemi, S. N., & Kirkwood, C. K. (1998). Elevation of nortriptyline plasma levels after cotreatment with paroxetine and thioridazine: Revista de Psicofarmacología Clínica Vol. 18(4) Ago 1998, 342-343. Gifford, S. D. (1979). A comparison of drug treatment for insomnia and the effect of causal attribution: Resúmenes de disertación internacional. gillis, J. S. (1979). Antipsychotic drugs and conflict resolution: A study of the comparative effects of trifluoperazine, haloperidol, and thioridazine: Research Communications in Psychology, Psychiatry & Behavior Vol 4(1) 1979, 3-20. gillis, J. S., & Davis, H. G. (1977). The effects of thioridazine and mesoridazine on the interpersonal learning of acute schizophrenics: Investigación terapéutica actual vol. 21(4) Apr 1977, 507-517. gillis, J. S., & Parkinson, S. C. (1977). The effects of phenothiazines on complex learning: Investigación terapéutica actual vol. 22(3) Sep 1977, 349-355. Giron, L. T., Jr. (1987). Tardive dystonia after a short course of thioridazine: The Journal of Family Practice Vol 24(4) Apr 1987, 405-406. Gittelman-Klein, R., & et al. (1976). Comparative effects of methylphenidate and thioridazine in hyperkinetic children: Yo. Clinical results: Archivos de Psiquiatría General Vol. 33(10) Oct 1976, 1217-1231. Glick, B. S. (1973). Comparison of doxepin and thioridazine in outpatients: Diseases of the Nervous System Vol 34(1) Ene 1973, 37-39. Goetz, C. G., Carvey, P. M., Tanner, C. M., & Klawans, H. L. (1984). Neuroleptic-induced dopamine hyposensitivity: Ciencias de la Vida Vol 34(15) Apr 1984, 1475-1479. Goldman, M. E. (1982). Effects of antidepressants on the central cholinergic nervous system: Resúmenes de disertación internacional. Goldstein, M. J., Acker, C. W., Crockett, J. T., & Riddle, J. J. (1966). Psychological reactions to films by chronic schizophrenics: Revista de psicología anormal vol. 71(5) Oct 1966, 335-344. Goldstein, S. E., & Birnbom, F. (1976). Piperacetazine versus thioridazine in the treatment of organic brain disease: A controlled double-blind study: Revista de la Sociedad Americana de Geriatría Vol 24(8) Ago 1976, 355-358. Goldwasser, H. D., Hooper, J. F., & Spears, N. M. (1989). Concomitant treatment of neuroleptic malignant syndrome and psychosis: Revista Británica de Psiquiatría Vol 154 Ene 1989, 102-104. Gottschalk, L. Un., Dinovo, E. C., & Nandi, B. R. (1978). Cerebrospinal fluid concentration of thioridazine and its metabolites in schizophrenic patients: Research Communications in Psychology, Psychiatry & Behavior Vol 3(2) 1978, 83-87. Gottschalk, L. Un., & et al. (1975). Thioridazine plasma levels and clinical response: Psiquiatría Integral Vol. 16(4) Navidad-agosto 1975, 323-337. Granacher, R. PAGS., & Ruth, D. D. (1982). A comparison of thioridazine (mellaril) and thiothixene (navane) in the treatment of hospitalized psychotic patients: Investigación terapéutica actual vol. 31(5) Mayo 1982, 692-705. Greenhill, L. L., Salomón, M., Pleak, R., & Ambrosini, P. (1985). Molindone hydrochloride treatment of hospitalized children with conduct disorder: Revista de Psiquiatría Clínica Vol 46(8, Secta 2) Ago 1985, 20-25. Grinspoon, L., Shader, R. Yo., Chatterjee, S., & Cohler, J. (1964). Side effects and double-blind studies: Yo. A clinical comparison between thioridazine hydrochloride and a combination of phenobarbital and atropine sulfate: Journal of Psychiatric Research 2(4) 1964, 247-256. Gualtieri, C. T., Lefler, W. H., Guimond, M., & Staye, J. Yo. (1982). Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine: Revista Americana de Psiquiatría Vol 139(9) Sep 1982, 1178-1180. Hamilton, J. D. (1985). Thioridazine retinopathy within the upper dosage limit: Psicosomática: Revista de Consulta Liaison Psychiatry Vol 26(10) Oct 1985, 823-824. Hanlon, T. E., Blatchley, R. J., & Kurland, Un. Un. (1975). Effects of control techniques on therapeutic outcome in a controlled clinical trial: International Pharmacopsychiatry Vol 10(3) 1975, 169-176. Harenko, Un., Alanen, Yo., Elovaara, S., Ginstrom, S., & et al. (1992). Zuclopenthixol and thioridazine in the treatment of aggressive, elderly patients: A double-blind, controlled, multicentre study: Revista internacional de psiquiatría geriátrica vol. 7(5) Mayo 1992, 369-375. Hayworth, R. M. (1973). Positive outcome in psychiatric crisis: Evaluation of thioridazine concentrate in an intensive, short-term psychiatric program: Psicosomática: Revista de Consulta Liaison Psychiatry Vol 14(1) Ene 1973, 42-45. Heistad, G. T., Zimmermann, R. L., & Doebler, M. Yo. (1982). Long-term usefulness of thioridazine for institutionalized mentally retarded patients: Revista estadounidense de deficiencia mental vol. 87(3) Nov 1982, 243-251. Hemet, C., Chassagne, PAGS., Levade, M.-H., Heron, F., & et al. (1994). Aseptic meningitis secondary to carbamazepine treatment of manic-depressive illness: Revista Americana de Psiquiatría Vol 151(9) Sep 1994, 1393. Herman, Z. S., Huzarska, M., Kmieciak-Kolada, K., & Kowalski, J. (1991). Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain: Psicofarmacología Vol. 104(1) Mayo 1991, 106-112. Herrara, J. J., & Vilaprino, J. J. (1964). Thioridazine in the treatment of manic psychoses: Acta Psiquiatrica y Psicologica de America Latina 10(3) 1964, 214-221. Herrera, J., Costa, J., Sramek, J., Heh, C., & et al. (1990). The efficacy of sustained-release thioridazine in the treatment of schizophrenic inpatients: Investigación terapéutica actual vol. 48(6) Dic 1990, 1006-1011. Chupetón, C., Stewart, C., & Lippmann, S. (1999). Olanzapine and NMS: Servicios psiquiátricos vol. 50(6) Jun 1999, 836-837. Hindmarch, Yo., & Tiplady, B. (1994). A comparison of the psychometric effects of remoxipride with those of haloperidol, thioridazine, and lorazepam in healthy volunteers: Psicofarmacología Humana: Clinical and Experimental Vol 9(1) ene-feb 1994, 43-49. Hine, B., Sakalis, G., & Gershon, S. (1979). Antagonism of amphetamine-induced stereotyped behavior in dogs by thioridazine and mesoridazine: Research Communications in Psychology, Psychiatry & Behavior Vol 4(1) 1979, 89-92. Hitri, Un. (1984). Biochemical reflections of striatal DA receptor activity in rats treated with chronic neuroleptic agents: Resúmenes de disertación internacional. Ho, B. T., & et al. (1982). Effects of neuroleptics on platelet monoamine oxidase activity: Psiquiatría Biológica Vol 17(8) Ago 1982, 885-895. Hoffer, Un. (1987). Further report on a schizophrenic patient who had hyperasparaginemia: Journal of Orthomolecular Medicine Vol 2(4) 1987, 213-216. Hubbard, J. W., Midha, K. K., Hawes, E. M., McKay, G., & et al. (1993). Metabolism of phenothiazine and butyrophenone antipsychotic drugs: A review of some recent findings and clinical implications: Revista Británica de Psiquiatría Vol 163(Suppl 22) Dic 1993, 19-24. Inayatulla, M., & Cantor, S. (1980). Effects of thioridazine on the cognitive functioning of a hypotonic schizophrenic boy: Revista Americana de Psiquiatría Vol 137(11) Nov 1980, 1459-1460. Iorio, L. C., Ryan, E. Un., & Gogerty, J. H. (1976). Combinations of selected CNS depressants with d-amphetamine or mazindol on food intake and motor activity of rats: European Journal of Pharmacology Vol 36(1) Estropear 1976, 89-94. Irlanda, W. PAGS., & Connell, B. J. (1990). Correlation between cellular changes in supraoptic and paraventricular nuclei and water-drinking in neuroleptic-treated rats: Investigación del cerebro conductual Vol 41(2) Dic 1990, 111-116. Johnson, G. F., & Hunt, G. E. (1980). The effect of thioridazine on prolactin levels in acutely schizophrenic patients: Challenge-dose and steady-state levels: Revista de psiquiatría de Australia y Nueva Zelanda, vol. 14(2) Jun 1980, 127-131. Johnston, B. (1972). Relief of mixed anxiety-depression in terminal cancer patients: Effect of thioridazine: New York State Journal of Medicine Vol 72(18) Sep 1972, 2315-2317. Johnston, J. M., & et al. (1983). Human operant laboratory measurement on the effects of chemical variables: Registro psicológico vol. 33(4) Fal 1983, 457-472. Kafi, Un. (1972). Thioridazine: Alleviation of the mixed anxiety-depressive psychoneurotic state: Behavioral Neuropsychiatry Vol 4(9-10) Dec-Jan 1972-1973, 13-15. Kasckow, J., Dolor, R., & Lipper, S. (1990). Delayed onset of neuroleptic malignant syndrome after discontinuation of thioridazine: Revista de Psicofarmacología Clínica Vol. 10(2) Apr 1990, 146. Kastenbaum, R., Slater, P. E., & Aisenberg, R. (1964). Toward a conceptual model of geriatric psychopharmacology: An experiment with thioridazine and dextroamphetamine: The Gerontologist 4(2, Pt 1) 1964, 68-71. Keks, N., McGrath, J., Lambert, T., Catts, S., & et al. (1994). The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia: Acta psiquiátrica Scandinavica vol. 90(5) Nov 1994, 358-365. Kelly, P. H., & Miller, R. J. (1975). The interaction of neuroleptic and muscarinic agents with central dopaminergic systems: British Journal of Pharmacology Vol 54(1) Mayo 1975, 115-121. Kelm, H. (1985). Phenothiazine therapy and perceptual changes in schizophrenia patients: Journal of Orthomolecular Psychiatry Vol 14(2) 1985, 92-96. Kessler, K. Un., & Waletzky, J. P. (1981). Clinical use of the antipsychotics: Revista Americana de Psiquiatría Vol 138(2) Feb 1981, 202-209. Kilts, C. D., & et al. (1984). Effects of thioridazine and its metabolites on dopaminergic function: Drug metabolism as a determinant of the antidopaminergic actions of thioridazine: Revista de Farmacología y Terapéutica Experimental Vol 231(2) Nov 1984, 334-342. Rey, R. P. (1984). Data utilization rules to assess thioridazine therapy in institutionalized mentally retarded people: Resúmenes de disertación internacional. Rey, S. M. (1975). State-dependent learning in retardates using thioridazine: Resúmenes de disertación internacional. Kiriike, N., Maeda, Y., Nishiwaki, S., Izumiya, Y., & et al. (1987). Iatrogenic torsade de pointes induced by thioridazine: Psiquiatría Biológica Vol 22(1) Ene 1987, 99-103. Kirven, L. E., & Montero, E. F. (1973). Comparison of thioridazine and diazepam in the control of nonpsychotic symptoms associated with senility: Double-blind study: Revista de la Sociedad Americana de Geriatría Vol 21(12) Dic 1973, 546-551. Klawans, H. L., Carvey, P. M., nelson, D., Tanner, C. M., & et al. (1986). The effect of thioridazine on haloperidol induced behavioral hypersensitivity: Ciencias de la Vida Vol 38(19) Mayo 1986, 1707-1714. Klein, R. G. (1990). Thioridazine effects on the cognitive performance of children with attention-deficit hyperactivity disorder: Revista de Psicofarmacología Infantil y Adolescente Vol. 1(4) 1990-1991, 263-270. Knijnik, L., Busnello, E. Un., & Oliveira, J. S. (1991). Therapeutic evaluation of thioridazine in comparison with chlorpromazine in stabilized schizophrenic patients: Jornal Brasileiro de Psiquiatria Vol 40(8) Sep 1991, 429-432. Konzett, H., Berner, W., & Lochs, H. (1973). Emotionally induced cardiovascular changes in man as a means for the investigation of tranquillizing drugs: Psychopharmacologia Vol 30(1) 1973, 75-82. Kotin, J., Wilbert, D. E., Verburg, D., & Seldinger, S. M. (1976). Thioridazine and sexual dysfunction: Revista Americana de Psiquiatría Vol 133(1) Ene 1976, 82-85. Kramer, M., & et al. (1978). Relative efficacy and safety of loxapine succinate (LoxitaneReg.) and thioridazine hydrochloride (MellarilReg.) in the treatment of acute schizophrenia: Investigación terapéutica actual vol. 23(5, Pt 2) Mayo 1978, 619-631. Kumar, B. B. (1979). An unusual case of akathisia: Revista Americana de Psiquiatría Vol 136(8) Ago 1979, 1088. Kurland, M. L. (1976). Neurotic depression: An empirical guide to two specific drug treatments: Diseases of the Nervous System Vol 37(8) Ago 1976, 424-431. Dejar, H., Carino, M. Un., & Horita, Un. (1981). Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal -3H-spiroperidol binding sites in the rat: Psicofarmacología Vol. 75(4) Dic 1981, 388-390. Lambert, T., Keks, N., McGrath, J., Catts, S., Hustig, H., Vaddadi, K., et al. (1995). Remoxipride versus thioridazine in the treatment of first episodes of schizophrenia in drug-naive patients: A case for specific, low potency D-sub-2 antagonists: Psicofarmacología Humana: Clinical and Experimental Vol 10(6) Nov-Dic 1995, 455-460. Lassen, J. B. (1975). Inhibition of 4, a-dimethyl-M-tyramine (H 77/77)-induced hypermotility in rats by single and repeated administration of chlorpromazine, haloperidol, clozapine and thioridazine: Psychopharmacologia Vol 43(1) 1975, 25-29. Lassen, J. B. (1977). Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone: Acta Pharmacologica et Toxicologica Vol 40(3) 1977, 418-429. Latimer, P. R., & Braden, D. H. (1975). Roussy-Levy syndrome with psychosis: The Canadian Psychiatric Association Journal / La Revue de l'Association des psychiatres du Canada Vol 20(4) Jun 1975, 287-289. Lázaro, Un., & Rosenberg, H. (1990). Treatment of rehospitalized NMS patients: Revista de Psiquiatría Clínica Vol 51(2) Feb 1990, 84. Leitersdorf, E., Goshen, R., & Shefer, Un. (1982). Atypical ventricular tachycardia in combined tetracyclic, antidepressant, neuroleptic and anticholinergic drugs interaction: Revista Internacional de Psiquiatría en Medicina Vol 12(2) 1982-1983, 85-91. Lewis, M. H., baumeister, Un. Un., McCorkle, D. L., & Mailman, R. B. (1985). A computer-supported method for analyzing behavioral observations: Studies with stereotypy: Psicofarmacología Vol. 85(2) Feb 1985, 204-209. Liljequist, R., & et al. (1975). Effect of two weeks' treatment with thioridazine, chlorpromazine, sulpiride, and bromazepam, alone or in combination with alcohol, on learning and memory in man: Psychopharmacologia Vol 44(2) 1975, 205-208. Lingl, F. Un. (1973). Double-blind comparison of haloperidol and thioridazine in treatment resistant psychoneurotic outpatients: Psicosomática: Revista de Consulta Liaison Psychiatry Vol 14(4) Jul 1973, 235-240. Linnoila, M., & Viukari, M. (1976). Efficacy and side effects of nitrazepam and thioridazine as sleeping aids in psychogeriatric in-patients: Revista Británica de Psiquiatría Vol 128 Jun 1976, 566-569. Llerena, Un., Berecz, R., de la Rubia, Un., & Dorado, P. (2002). QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients: Journal of Psychopharmacology Vol 16(4) Dic 2002, 361-364. Lofft, J. G., & Demars, J. P. (1974). A chemotherapeutic alternative to the antianxiety agents for the extended treatment of psychoneurosis: Diseases of the Nervous System Vol 35(9) Sep 1974, 409-415. Loubier, D., Dravet, C., & Soulayrol, R. (1973). Preliminary findings of a therapeutic experiment: Thioridazine for epileptic children: Revue de Neuropsychiatrie Infantile et d'Hygiene Mentale de l'Enfance Vol 21(9) Sep 1973, 559-564. Luchins, D. J., & et al. (1978). Filicide during psychotropic-induced somnambulism: Un informe de caso: Revista Americana de Psiquiatría Vol 135(11) Nov 1978, 1404-1405. Maany, Yo., O'Brien, C. PAGS., & Woody, G. (1987). Interaction between thioridazine and naltrexone: Revista Americana de Psiquiatría Vol 144(7) Jul 1987, 966. Mailman, R. B., Widerlov, E., Kilts, C. D., & Lewis, M. H. (1985). Thioridazine: An atypical neuroleptic drug? Overview of the pharmacodynamic effects of thioridazine and its active metabolites: Nordisk Psykiatrisk Tidsskrift Vol 39(5) 1985, 395-404. Manchanda, R. (1986). Criteria for measuring change: Statistical significance vs clinical significance: Revista Británica de Psiquiatría Vol 148 Jun 1986, 744-745. Martensson, E., Nyberg, G., axelsson, R., & Serck-Hansen, K. (1975). Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients: Investigación terapéutica actual vol. 18(5) Nov 1975, 687-700. Martinez Aparicio, R., & et al. (1977). Thioridazine in chronic psychoses: Revista Colombiana de Psiquiatria Vol 6(2) Jun 1977, 179-184. Martínez, G. Un. (1965). Thioridazine (Mellaril) in behavior problems in children: Acta Psiquiatrica y Psicologica de America Latina 11(2) 1965, 157-162. matthews, T., & Weston, S. N. (2003). Experience of thioridazine use before and after the Committee on Safety of Medicines warning: Boletín Psiquiátrico Vol. 27(3) Estropear 2003, 87-89. Matuk, F., & Kalyanaraman, K. (1977). Syndrome of inappropriate secretion of antidiuretic hormone in patients treated with psychotherapeutic drugs: Archivos de neurología vol. 34(6) Jun 1977, 374-375. McCarthy, S. T., John, S. M., McCarthy, G. L., & Wollner, L. (1986). The influence of chlormethiazole in comparison to thioridazine on body temperature and postural hypotension in healthy adults and healthy elderly volunteers: Acta psiquiátrica Scandinavica vol. 73(329, Suppl) 1986, 40-44. McCreadie, R. G., Todd, N., Lívingston, M., Eccleston, D., & et al. (1988). A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia: Acta psiquiátrica Scandinavica vol. 78(1) Jul 1988, 49-56. McCreadie, R. G., Todd, N., Lívingston, M. G., Eccleston, D., & et al. (1990). A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia: Acta psiquiátrica Scandinavica vol. 82(358, Suppl) 1990, 136-137. McLennan, J., Findlay, D. J., Sharma, J., McEwen, J., & et al. (1992). Prolactin response to withdrawal of thioridazine in dementia: Revista internacional de psiquiatría geriátrica vol. 7(10) Oct 1992, 739-742. McNamee, H. B., Le Poidevin, D., & Naylor, G. J. (1972). Methysergide in mania: A double-blind comparison with thioridazine: Medicina Psicológica Vol. 2(1) Feb 1972, 66-69. Melnyk, W. T., Worthington, Un. G., & Laverty, S. G. (1966). Abrupt withdrawal of chlorpromazine and thioridazine from schizophrenic in-patients: The Canadian Psychiatric Association Journal / La Revue de l'Association des psychiatres du Canada 11(5) 1966, 410-413. Menkes, D. B., & Knight, J. C. (2002). Cardiotoxicity and prescription of thioridazine in New Zealand: Revista de psiquiatría de Australia y Nueva Zelanda, vol. 36(4) Ago 2002, 492-498. Menolascino, F. J., Reudrich, S. L., Golden, C. J., & Wilson, J. (1985). Schizophrenia in the mentally retarded: A comparative study of the therapeutic efficacy of thiothixene and thioridazine: Psychiatric Hospital Vol 16(1) Victoria 1985, 21-25. Menolascino, F. J., wilson, J., Golden, C. J., & Ruedrich, S. L. (1986). Medication and treatment of schizophrenia in persons with mental retardation: Mental Retardation Vol 24(5) Oct 1986, 277-283. Molcan, J., & Polak, L. (1986). Butyrophenones (pimozide, penfluridol, haloperidol) are superior to thioridazine in tics in children: Activitas Nervosa Superior Vol 28(1) 1986, 37. Mons, J., Senes, M., & Ajzenberg, D. (1964). A year of application of thioridazine in a psychiatric setting (regarding 300 observaciones): L'Encephale 53(1) 1964, 196-202. montgomery, S. Un., Verde, M., Rimon, R., Heikkila, L., & et al. (1992). Inadequate treatment response to des-enkaphalin-gamma-endorphin compared with thioridazine and placebo in schizophrenia: Acta psiquiátrica Scandinavica vol. 86(2) Ago 1992, 97-103. Nachin, C. (1973). Reflection of 12 years use of thioridazine: With reference to 198 Casos: Annales Medico-Psychologiques Vol 1(4) Apr 1973, 535-542. Nahunek, K., & et al. (1981). The efficacy of tranylcypromine, nortriptyline, thioridazine and amitriptyline in two syndromological types of endogenous depression: A comparison: Activitas Nervosa Superior Vol 23(3) Sep 1981, 198-200. Nahunek, K., & et al. (1982). Comparison of the effect of target-syndrome antidepressive therapy in three syndromologic types of endogenous depression: Activitas Nervosa Superior Vol 24(4) 1982, 211-213. Nahunek, K., Svestka, J., Rysanek, R., Ceskova, E., & et al. (1986). Full therapeutic success of repeated treatment in most "drug resistant" cases of endogenous depression: Activitas Nervosa Superior Vol 28(4) Dic 1986, 302-303. Nakagami, T., Yasui-Furukori, N., Saito, M., Mihara, K., De Vries, R., Kondo, T., et al. (2005). Thioridazine Inhibits Risperidone Metabolism: A Clinically Relevant Drug Interaction: Revista de Psicofarmacología Clínica Vol. 25(1) Feb 2005, 89-91. Nishikawa, T., & et al. (1985). Prophylactic effects of neuroleptics in symptom-free schizophrenics: Roles of dopaminergic and noradrenergic blockers: Psiquiatría Biológica Vol 20(11) Nov 1985, 1161-1166. Nistri, M., & Deluca, P. L. (1964). Inhibition of ejaculation during treatment with thioridazine: Its eventual therapeutic value: L'Encephale 53(1) 1964, 203-206. Nodar, R. H., & Smith, J. H. (1970). Averaged electroencephalic audiometry applied to medicated mentally retarded adults during sleep: Revista de investigación auditiva vol. 10(3) Jul 1970, 221-225. norris, M. S., Mathew, R. J., & Webb, W. W. (1983). Delirium associated with lithium-induced hypothyroidism: Un informe de caso: Revista Americana de Psiquiatría Vol 140(3) Estropear 1983, 355-356. Parkinson, S. C., & Gillis, J. S. (1977). The subjective effects of selected phenothiazines: Research Communications in Psychology, Psychiatry & Behavior Vol 2(5-6) 1977, 297-312. Pena-Ramos, Un. (1977). Thioridazine HCl vs. chlordiazepoxide HCl in controlling symptoms attributable to alcohol withdrawal: Diseases of the Nervous System Vol 38(3) Estropear 1977, 144-147. Petrides, Un. (1973). Thioridazine for newly admitted psychiatric patients: Investigación terapéutica actual vol. 15(3) Estropear 1973, 116-122. Phanjoo, Un. L., & Link, C. (1990). Remoxipride versus thioridazine in elderly psychotic patients: Acta psiquiátrica Scandinavica vol. 82(358, Suppl) 1990, 181-185. Piazza, P. V., Calza, L., Giardino, L., & Amato, G. (1990). Chronic thioridazine treatment differently affects DA receptors in striatum and in mesolimbo-cortical systems: Farmacología, Bioquímica y Comportamiento Vol. 35(4) Apr 1990, 937-942. Pico Costero, J., Abreu de la Torre, C., & Roque Banos, L. (1986). Premature ejaculation: Treatment with thioridazine: Revista del Hospital Psiquiatrico de La Habana Vol 27(2) Abr-Jun 1986, 277-280. Polak, L., Molcan, J., & Dimova, N. (1985). Butyrophenons are superior to thioridazine in the treatment of tic in children: Activitas Nervosa Superior Vol 27(1) 1985, 46-47. Preskorn, S. H. (2005). The Difference Between the Formal and the Functional Dose: The Case of the Patient on Thioridazine and Fluvoxamine: Revista de práctica psiquiátrica vol. 11(3) Mayo 2005, 192-196. Prueter, C., Schiefer, J., Norra, C., Podoll, K., & Sass, H. (2001). Ping-pong gaze in combined intoxication with tranylcypromine, thioridazine, and clomipramine: Neurosiquiatría, Neuropsicología, & Behavioral Neurology Vol 14(4) Oct-Dic 2001, 246-247. Rada, R. T., & Donlon, P. T. (1972). Piperacetazine vs thioridazine for the control of schizophrenia in outpatients: Psicosomática: Revista de Consulta Liaison Psychiatry Vol 13(6) Nov 1972, 373-376. Rainaut, J. (1975). Statistical analysis of the comparative double-blind study of the activity of loxapine and thioridazine: L'Encephale Vol 1(2) Feb 1975, 147-160. Rao, M. L., & Brown, W. Un. (1987). Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients: Psicofarmacología Vol. 93(2) Oct 1987, 237-242. Rayevsky, K. S., Gainetdinov, R. R., Grekhova, T. V., & Sotnikova, T. D. (1995). Regulation of dopamine release and metabolism in rat striatum In Vivo: Effects of dopamine receptor antagonists: Progress in Neuro-Psychopharmacology & Biological Psychiatry Vol 19(8) Dic 1995, 1285-1303. Realmuto, G. M., & et al. (1984). Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents: Revista Americana de Psiquiatría Vol 141(3) Estropear 1984, 440-442. Remr, J., Nekolova, J., & Heinzl, Z. (1975). Comparison of the effect of oxypertine and thioridazine on sensorimotor activity in chronic schizophrenics: A controlled study: Activitas Nervosa Superior Vol 17(4) 1975, 213-214. Remy, M. (1964). The prolonged usage of Mellaril in clinical psychiatry: L'Encephale 53(1) 1964, 187-191. Rickels, K., & et al. (1974). Thiothixene and thioridazine in anxiety: Revista Británica de Psiquiatría Vol 125 Jul 1974, 79-87. robertson, Un., Campbell, C., & MacDonald, C. (1986). Evidence that thioridazine enhances amphetamine-induced stereotypy via anticholinergic activity: Progress in Neuro-Psychopharmacology & Biological Psychiatry Vol 10(1) 1986, 33-40. robertson, Un., & MacDonald, C. (1986). The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors: Farmacología, Bioquímica y Comportamiento Vol. 24(6) Jun 1986, 1639-1643. Rosa, H. J. (1979). Double-blind comparison of haloperidol and thioridazine in geriatric outpatients: Revista de Psiquiatría Clínica Vol 40(1) Ene 1979, 24-31. Roszell, D. K., & Horita, Un. (1975). The effects of haloperidol and thioridazine on apomorphine- and LSD-induced hyperthermia in the rabbit: Revista de Investigación Psiquiátrica Vol 12(2) Ago 1975, 117-123. Rotrosen, J., Wallach, M. B., Angrist, B., & Gershon, S. (1972). Antagonism of apomorphine-induced stereotypy and emesis in dogs by thioridazine, haloperidol, and pimozide: Psychopharmacologia Vol 26(2) 1972, 185-194. Saario, Yo. (1976). Psychomotor skills during subacute treatment with thioridazine and bromazepam, and their combined effects with alcohol: Annals of Clinical Research Vol 8(2) Apr 1976, 117-123. Sachar, E. J., & et al. (1975). Thioridazine stimulates prolactin secretion in man: Archivos de Psiquiatría General Vol. 32(7) Jul 1975, 885-886. Safko, S., & Klimo, Z. (1972). Casuistic contribution to the problem of pathological laughter: Ceskoslovenska Psychiatrie Vol 68(1) Feb 1972, 32-34. Sakalis, G., Traficante, L. J., & Gershon, S. (1977). Thioridazine metabolism and clinical response: A pilot study: Investigación terapéutica actual vol. 21(5) Mayo 1977, 720-724. Salamone, J. D., Cousins, M. S., Maio, C., Campeón, M., & Turski, T. (1996). Different behavioral effects of haloperidol, clozapine and thioridazine in a concurrent lever pressing and feeding procedure: Psicofarmacología Vol. 125(2) Mayo 1996, 105-112. Salde, H. (1964). Thioridazine in the treatment of chronic psychoses: L'Encephale 53(1) 1964, 285-288. Saxe, C. L. (1985). One year analysis of thioridazine(Mellaril) withdrawal effects on maladaptive responses and responses to instruction in a controlled environment: Resúmenes de disertación internacional. Schneider, S. J. (1982). Electrodermal activity and therapeutic response to neuroleptic treatment in chronic schizophrenic in-patients: Medicina Psicológica Vol. 12(3) Ago 1982, 607-613. Schnetzler, J. PAGS., Lamand, J. C., Cassassuce, J., & Carrel, M. (1964). The effects of neuroleptics in general and of thioridazine in particular on sexuality: L'Encephale 53(1) 1964, 207-214. Scott, Un. Yo. (1988). Attempted strangulation during phenothiazine-induced sleep-walking and night terrors: Revista Británica de Psiquiatría Vol 153 Nov 1988, 692-694. Sell, M. B. (1985). Sensitization to thioridazine through sexual intercourse: Revista Americana de Psiquiatría Vol 142(2) Feb 1985, 271-272. Sewell, D. D., Jeste, D. V., McAdams, L. Un., Muralla exterior, Un., & et al. (1994). Neuroleptic treatment of HIV-associated psychosis: Neuropsychopharmacology Vol 10(4) Jul 1994, 223-229. Shen, W. W., & Park, S. (1982). Thioridazine-induced inhibition of female orgasm: Revista psiquiátrica de la Universidad de Ottawa Vol 7(4) Dic 1982, 249-251. Shen, W. W., Sata, L. S., & Hofstatter, L. (1984). Thioridazine and understanding sexual phases in both sexes: Revista psiquiátrica de la Universidad de Ottawa Vol 9(4) Dic 1984, 187-190. Shenoy, R. S. (1980). Nocturnal enuresis caused by psychotropic drugs: Revista Americana de Psiquiatría Vol 137(6) Jun 1980, 739-740. Sidorowicz, S., Chyczewski, T., Janicka, B., Sanecka, B., & et al. (1986). Serum thioridazine concentration and the antipsychotic effect measured with a general scale of psychopathology Vol 4(2) Suma 1994, 93-99. Singh, N. N., Landrum, T. J., Ellis, C. R., & Donatelli, L. S. (1993). Effects of thioridazine and visual screening on stereotypy and social behavior in individuals with mental retardation: Research in Developmental Disabilities Vol 14(3) Mayo-Junio 1993, 163-177. Singh, N. N., & Winton, Un. S. (1984). Behavioral monitoring of pharmacological interventions for self-injury: Applied Research in Mental Retardation Vol 5(1) 1984, 161-170. Herrero, R. C., Baumgartner, R., Ravichandran, G. K., Largen, J., & et al. (1987). Cortical atrophy and white matter density in the brains of schizophrenics and clinical response to neuroleptics: Acta psiquiátrica Scandinavica vol. 75(1) Ene 1987, 11-19. Herrero, R. C., & Davis, J. M. (1976). Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine: Ciencias de la Vida Vol 19(5) Sep 1976, 725-732. Smythies, J. R., & Beaton, J. M. (1974). A pilot study of pimozide in schizophrenia: Revista de Investigación Psiquiátrica Vol 11 1974, 71-72. Sovner, R. (1995). Thioridazine withdrawal-induced behavioral deterioration treated with clonidine: Two case reports: Mental Retardation Vol 33(4) Ago 1995, 221-225. Sovner, R., & Hurley, Un. D. (1986). Drug profiles: II. Mesoridazine and thioridazine: Psychiatric Aspects of Mental Retardation Reviews Vol 5(6-7) Jun-Jul 1986, 27-37. Primavera, G. K. (1979). Neurotoxicity with combined use of lithium and thioridazine: Revista de Psiquiatría Clínica Vol 40(3) Estropear 1979, 135-138. Stabenau, J. R., & Grinols, D. R. (1964). A double-blind comparison of thioridazine and chlorpromazine: Psychiatric Quarterly 38(1) 1964, 42-63. Stabl, M., Kasas, Un., Blajev, B., Bajetta, G., & et al. (1995). A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression: Revista de Psicofarmacología Clínica Vol. 15(4, Suppl 2) Ago 1995, 41S-45S. Stahl, S. M. (1980). Tardive Tourette syndrome in an autistic patient after long-term neuroleptic administration: Revista Americana de Psiquiatría Vol 137(10) Oct 1980, 1267-1269. Starace, C. J. (1972). Psychoactive medication and concern: The urban physician's practical Rx for neuroses: Psicosomática: Revista de Consulta Liaison Psychiatry Vol 13(4) Jul 1972, 251-254. Steele, C., Lucas, M. J., & Tune, L. (1986). Haloperidol versus thiordazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: Conclusiones preliminares: Revista de Psiquiatría Clínica Vol 47(6) Jun 1986, 310-312. Svendsen, C. N., & Bird, E. D. (1986). HPLC with electrochemical detection to measure chlorpromazine, thioridazine and metabolites in human brain: Psicofarmacología Vol. 90(3) Oct 1986, 316-321. Svendsen, C. N., Froimowitz, M., Hrbek, C., Campbell, Un., & et al. (1988). Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: Evidence for different stereoselectivities at D-sub-1 and D-sub-2 receptors in rat brain: Neuropharmacology Vol 27(11) Nov 1988, 1117-1124. Svendsen, C. N., Hrbek, C. C., Casendino, M., Nichols, R. D., & et al. (1988). Concentration and distribution of thioridazine and metabolites in schizophrenic post-mortem brain tissue: Psychiatry Research Vol 23(1) Ene 1988, 1-10. Svensson, C., Nyberg, G., axelsson, R., & Martensson, E. (1986). Concentrations of thioridazine and thioridazine metabolites in erythrocytes: Psicofarmacología Vol. 89(3) Jul 1986, 291-292. Szabadi, E., Bradshaw, C. M., & Gaszner, P. (1980). The comparison of the effects of DL-308, a potential new neuroleptic agent, and thioridazine on some psychological and physiological functions in healthy volunteers: Psicofarmacología Vol. 68(2) Mayo 1980, 125-134. Takeichi, M. (1976). Effect of chronic thioridazine (melleril) administration to rat myocardium: Ultrastructural analysis: Kyushu Neuro-psychiatry Vol 22(3-4) 1976, 229-241. Tate, D. L. (1976). The effects of methylphenidate and thioridazine upon attention, excitación, and activity in mentally retarded youngsters: Resúmenes de disertación internacional. Tekell, J. L., silva, J. Un., Maas, J. Un., Bowden, C. L., & et al. (1996). Thioridazine-induced retinopathy: Revista Americana de Psiquiatría Vol 153(9) Sep 1996, 1234-1235. Thaker, G. K., Alphs, L., & Tamminga, C. Un. (1985). Labile hypertension after antipsychotic drug withdrawal: Un informe de caso: Psiquiatría Biológica Vol 20(11) Nov 1985, 1244-1246. Tiihonen, J., Vartiainen, H., & Hakola, P. (1995). Carbamazepine-induced changes in plasma levels of neuroleptics: Farmacopsiquiatría Vol. 28(1) Ene 1995, 26-28. Timell, Un. M. (2000). Thioridazine: Re-evaluating the risk/benefit equation: Annals of Clinical Psychiatry Vol 12(3) Sep 2000, 147-151. Timell, Un. M. (2003). Re: Thioridazine: Re-evaluating the Risk/Benefit Equation: Annals of Clinical Psychiatry Vol 15(2) Jun 2003, 131-131. Traficante, L. J., Hine, B., Gershon, S., & Sakalis, G. (1977). Chloroquine potentiation of thioridazine effects in rats and drug-resistant schizophrenic patients: A preliminary report: Communications in Psychopharmacology Vol 1(4) 1977, 407-419. Trevitt, J., Atherton, Un., Aberman, J., & Salamone, J. D. (1998). Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat: Psicofarmacología Vol. 137(1) Mayo 1998, 61-66. Trevitt, J. T., lyon, M., Aberman, J., Carriero, D., Finn, M., & Salamone, J. D. (1997). Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function: Psicofarmacología Vol. 132(1) Jul 1997, 74-81. Tschanz, J. T., & Rebec, G. V. (1988). Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy: Farmacología, Bioquímica y Comportamiento Vol. 31(3) Nov 1988, 519-522. Tune, L. E., Steele, C., & Cooper, T. (1991). Neuroleptic drugs in the management of behavioral symptoms of Alzheimer's disease: Psychiatric Clinics of North America Vol 14(2) Jun 1991, 353-373. Turek, Yo. S., & et al. (1973). Tiotixene and thioridazine in alcoholism treatment: Quarterly Journal of Studies on Alcohol Vol 34(3, Pt A) Sep 1973, 853-859. Vaisanen, K., Viukari, M., Rimon, R., & Raisanen, P. (1981). Haloperidol, thioridazine and placebo in mentally subnormal patients--serum levels and clinical effects: Acta psiquiátrica Scandinavica vol. 63(3) Estropear 1981, 262-271. Velek, M., Stanford, G. K., & Marco, L. (1987). Priapism associated with concurrent use of thioridazine and metoclopramide: Revista Americana de Psiquiatría Vol 144(6) Jun 1987, 827-828. Vital-Herne, J., Gerbino, L., Kay, S. R., Katz, Yo. R., & et al. (1986). Mesoridazine and thioridazine: Clinical effects and blood levels in refractory schizophrenics: Revista de Psiquiatría Clínica Vol 47(7) Jul 1986, 375-379. Vojtechovsky, M., & Kral, J. (1975). Chlorprothixene and thioridazine in maintenance therapy of longterm hospital psychotics: Activitas Nervosa Superior Vol 17(4) 1975, 212-213. Vostatek, M. (1992). Monitoring of chlorpromazine and thioridazine levels in patients' urine: Cesko-Slovenska Psychiatrie Vol 88(1) Ene 1992, 51-54. Walinder, J., Skott, Un., Carlsson, Un., & Roos, B.-E. (1976). Potentiation by metyrosin of thioridazine effects in chronic schizophrenics: A long-term trial using double-blind cross-over technique: Archivos de Psiquiatría General Vol. 33(4) Apr 1976, 501-505. Weingarten, J. C., & Thompson, T. L. (1985). The effect of thioridazine on prolactinoma growth in a schizophrenic man: Caso clínico: Hospital General de Psiquiatría Vol 7(4) Oct 1985, 364-366. Oeste, N. R., & et al. (1974). Assay procedures for thioridazine, trifluoperazine, and their sulfoxides and determination of urinary excretion of these compounds in mental patients: Journal of Pharmaceutical Sciences Vol 63(3) Estropear 1974, 417-420. Weston, M. J., & et al. (1973). A comparative trial of haloperidol and thioridazine: Management of chronic schizophrenia: Revista de psiquiatría de Australia y Nueva Zelanda, vol. 7(1) Estropear 1973, 52-57. Widerlov, E., & et al. (1982). Serum concentrations of thioridazine, its major metabolites and serum neuroleptic-like activities in schizophrenics with and without tardive dyskinesia: Acta psiquiátrica Scandinavica vol. 66(4) Oct 1982, 294-305. Wilens, T. E., & Stern, T. Un. (1990). Ventricular tachycardia associated with desipramine and thioridazine: Psicosomática: Revista de Consulta Liaison Psychiatry Vol 31(1) Victoria 1990, 100-103. Windhager, E., Leblhuber, F., & Puhringer, W. (1990). Neuroleptic treatment after episode of neuroleptic malignant syndrome: Acta psiquiátrica Scandinavica vol. 82(3) Sep 1990, 268. Wittenborn, J. R., & Kiremitci, N. (1975). A comparison of antidepressant medications in neurotic and psychotic patients: Archivos de Psiquiatría General Vol. 32(9) Sep 1975, 1172-1176. Wittenborn, J. R., Kiremitci, N., & Weber, E. S. (1973). The choice of alternative antidepressants: Revista de Enfermedades Nerviosas y Mentales Vol 156(2) Feb 1973, 97-108. Woodruff, P. W., Palazidou, E., Cranston, Yo., Toone, B. K., & et al. (1991). Neoplasia and the neuroleptic malignant syndrome: Psicofarmacología Humana: Clinical and Experimental Vol 6(3) Sep 1991, 257-260. Wright, N. (2001). Removal of thioridazine from primary care formulary will result in prescribing vacuum: BMJ: British Medical Journal Vol 323(7314) Sep 2001, 695. Wysocki, T., Fuqua, R. W., Davis, V. J., & Breuning, S. E. (1981). Effects of thioridazine (Mellaril) on titrating delayed matching-to-sample performance of mentally retarded adults: Revista estadounidense de deficiencia mental vol. 85(5) Estropear 1981, 539-547. Wysocki, T. T. (1980). Effects of thioridazine (mellaril) on titrating delayed matching to sample performance in mentally retarded adults: Resúmenes de disertación internacional. Yassa, R. (1983). Thioridazine and sexual dysfunction: A case report and review of the literature: Journal of Psychiatric Treatment & Evaluation Vol 5(2-3) 1983, 185-186. Yildiz, Un., Alkin, T., Ozerdem, Un., Sagduyu, K., & Demopulos, C. M. (2003). Neuroleptic malignant syndrome: a case that may shed new light into the etiology and treatment: Revista de psiquiatría de Australia y Nueva Zelanda, vol. 37(4) Ago 2003, 493-494. Zivkovic, B., Guidotti, Un., Revuelta, Un., & Costa, E. (1975). Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens: Revista de Farmacología y Terapéutica Experimental Vol 194(1) Jul 1975, 37-46. External links PubChem Substance Summary: Thioridazine National Center for Biotechnology Information,. This box: view • talk • edit Psycholeptics: antipsicóticos (N05A) Phenothiazine typical antipsychotics Chlorpromazine • Fluphenazine • Mesoridazine • Perphenazine • Prochlorperazine • Promazine • Thioridazine/Sulforidazine • Trifluoperazine Other typical antipsychotics Indoles (Molindone) • Butyrophenones (Azaperone, Benperidol, Droperidol, Haloperidol) • Thioxanthenes (Flupentixol, Chlorprothixene, Thiothixene, Zuclopenthixol) • diphenylbutylpiperidines (Fluspirilene, Penfluridol, Pimozide) • other (Loxapine) Atypical antipsychotics Butyrophenones (Melperone) • Indoles (Sertindole, Ziprasidone) • Benzamides (Sulpiride, Remoxipride, Amisulpride) • diazepines/oxazepines/thiazepines (Clozapine, Olanzapine, Quetiapine) • other (Aripiprazole, Risperidone, Paliperidone, Zotepine) Esta página utiliza contenido con licencia Creative Commons de Wikipedia (ver autores).

Si quieres conocer otros artículos parecidos a Thioridazine puedes visitar la categoría Articles with sections needing expansion.

Deja una respuesta

Tu dirección de correo electrónico no será publicada.

Subir

we use own and third party cookies to improve user experience More information